Hamlet PharmaHamlet PharmaHamlet Pharma
  • Home
  • About Hamlet Pharma
    • Finance and Strategy
    • Patents
    • Who Gets Cancer
  • Clinical Trials
  • Science
  • Investors
    • Financial Reports
    • Annual General Meeting 2020
  • News
  • Contact
Hamlet Pharma
Category

News

NewsPressmeddelande

Dose-escalation study initiated

News

This is HAMLET – The movie

News

Alpha1H Patent granted in Europe

News

BAMLET in non-prescription products

News

Neutraceutical Patent granted in Europe

NewsPressmeddelande

Hamlet Pharma-BC Kick-off meeting

News

BAMLET treatment of colon cancer in an animal model

NewsPressmeddelande

Hamlet Pharma Starts Two Parallel Clinical Study Programs

NewsPressmeddelande

Hamlet Pharma regains patent rights for BAMLET

NewsPressmeddelande

Hamlet Pharma builds for a promising future

1 2 3 Next

HAMLET Pharma AB is a pharmaceutical company with strong links to research, working with natural and biological substances.

Swedish

© 2021 Hamlet Pharma.

  • Home
  • About Hamlet Pharma
    • Finance and Strategy
    • Patents
    • Who Gets Cancer
  • Clinical Trials
  • Science
  • Investors
    • Financial Reports
    • Annual General Meeting 2020
  • News
  • Contact

Hamlet Pharma AB

BMC D10
Klinikgatan 32
SE-222 42 Lund, Sweden
+46 40 12 25 00
info@hamletpharma.com

Swedish